Hermann Einsele

75.2k citations
772 papers · 30.4k · 11 hit papers · h-index 87

Impact in

  • Hematology top 0.02%
    • Multiple Myeloma Research and Treatments
    • Hematopoietic Stem Cell Transplantation
  • Oncology top 0.05%
    • CAR-T cell therapy research

Papers in

    • Multiple Myeloma Research and Treatments 246
    • Hematopoietic Stem Cell Transplantation 74
    • CAR-T cell therapy research 121

Hermann Einsele

742 papers receiving 29.8k citations

Hermann Einsele's Hit Papers

Therapeutic advances of targeting receptor tyrosine kinases in cancer 2024 · 107 citations
1070+6+13Years since publication2505007501000

Peers

Hermann Einsele
Comparison fields: 5 of 158
  • Hematology 7.8k
  • Oncology 11.3k
  • Infectious Diseases 5.6k
  • Immunology 5.4k
  • Epidemiology 7.6k
Replace Per Ljungman with:
Per Ljungman Sweden
William J. Sandborn United States
Elias Anaissie United States
Tsutomu Takeuchi Japan
Richard E. Champlin United States
Jan J. Cornelissen Netherlands
Paul Rutgeerts Belgium
Daniel J. Weisdorf United States
Michael Boeckh United States
Philippe Moreau France
Hermann Einsele relative to Per Ljungman Sweden Per Ljungman's profile →
Citations per field
00.5×2.8×
Per Ljungman · 1×
Citations per year

Countries citing papers authored by Hermann Einsele

Since Specialization
Citations

This map shows the geographic impact of Hermann Einsele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hermann Einsele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hermann Einsele more than expected).

Fields of papers citing papers by Hermann Einsele

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hermann Einsele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hermann Einsele. The network helps show where Hermann Einsele may publish in the future.

Co-authors

The 25 scholars most cited alongside Hermann Einsele, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hermann Einsele Line = papers co-authored together Hermann Einsele links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 772 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
Hit paper breakdown →
20091166
2
Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody
Hit paper breakdown →
2008808
3
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma
Hit paper breakdown →
2007632
4
Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Gemcitabine Alone in Advanced Pancreatic Cancer
Hit paper breakdown →
2006535
5
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Hit paper breakdown →
2017525
6
Phase II Trial of the Anti-CD19 Bispecific T Cell–Engager Blinatumomab Shows Hematologic and Molecular Remissions in Patients With Relapsed or Refractory B-Precursor Acute Lymphoblastic Leukemia
Hit paper breakdown →
2014494
7
Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
Hit paper breakdown →
2021491
8 1997462
9
The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells
Hit paper breakdown →
2019388
10 2010340
11 2006337
12 2016294
13 2008292
14 2008291
15 1997278
16 2012246
17 2009240
18
Anti–B-Cell Maturation Antigen BiTE Molecule AMG 420 Induces Responses in Multiple Myeloma
Hit paper breakdown →
2020239
19 2009236
20 2000231

About Hermann Einsele

Hermann Einsele is a scholar working on Hematology, Oncology, Molecular Biology, Epidemiology and Immunology, having authored 772 papers that have together received 30.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (246 papers), CAR-T cell therapy research (121 papers), Antifungal resistance and susceptibility (108 papers), Fungal Infections and Studies (80 papers), Hematopoietic Stem Cell Transplantation (74 papers), Cytomegalovirus and herpesvirus research (73 papers), Protein Degradation and Inhibitors (70 papers) and Immune Cell Function and Interaction (61 papers). The work is most often cited by research in Hematology (7.8k citations), Oncology (11.3k citations), Infectious Diseases (5.6k citations), Immunology (5.4k citations) and Epidemiology (7.6k citations). Hermann Einsele has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Holger Hebart, Juergen Loeffler, Ulrike Schumacher, Jürgen Löffler, Michael Hudecek, Michael Boeckh, Per Ljungman, Jan Storek, Stefan Knop and Ralf C. Bargou. Their work appears in journals such as Blood, Journal of Clinical Oncology, Bone Marrow Transplantation, Annals of Hematology and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact